SPONSORED CONTENT
State-level oversight of the 340B Drug Pricing Program continues to expand. In 2025 alone, states including Colorado, Hawaii, Idaho, Indiana, Ohio, Rhode Island, and Vermont enacted laws requiring covered entities to report acquisition costs, reimbursement, and the use of 340B program savings.
…






